Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial brachytherapy.

M W McDermott1, P H Gutin, D A Larson

  • 1Department of Surgery, University of British Columbia, Vancouver, Canada.

Neurosurgery Clinics of North America
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes.

AJNR. American journal of neuroradiology·2019
Same author

Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI.

Clinical radiology·2015
Same author

Delayed neurological deficit following resection of tuberculum sellae meningioma: report of two cases, one with permanent and one with reversible visual impairment.

Acta neurochirurgica·2014
Same author

Recurrent syncope due to refractory cerebral venous sinus thrombosis and transient elevations of intracranial pressure.

The Neurohospitalist·2014
Same author

Super-resolution track density imaging of glioblastoma: histopathologic correlation.

AJNR. American journal of neuroradiology·2013
Same author

Impact of dose hot spots on spinal cord tolerance following stereotactic body radiotherapy: a generalized biological effective dose analysis.

Technology in cancer research & treatment·2011
Same journal

Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Spinal Cord Deformities Associated with Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Radiation Therapy for Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Treatment Strategies of Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Vascular Lesions of the Spinal Cord: Arteriovenous and Cavernous Malformations.

Neurosurgery clinics of North America·2026
Same journal

Hemangioblastomas of the Spinal Cord.

Neurosurgery clinics of North America·2026
See all related articles

Interstitial brachytherapy shows promise for treating recurrent malignant gliomas. Further research is needed to confirm its effectiveness for newly diagnosed tumors and assess combined treatments.

Area of Science:

  • Neurosurgery
  • Radiation Oncology
  • Oncology

Background:

  • Renewed interest in interstitial brachytherapy for malignant gliomas and cerebral metastases.
  • Current use for both newly diagnosed and recurrent tumors.
  • Variety of techniques for radioactive isotope implantation exist.

Purpose of the Study:

  • Evaluate the efficacy of interstitial brachytherapy.
  • Confirm its use in the adjuvant setting for newly diagnosed tumors.
  • Determine the impact of hyperthermia or chemotherapy on outcomes.

Main Methods:

  • Stereotactic implantation of radioactive isotopes.
  • Utilizing various planning and implantation techniques.
  • Investigating outcomes in recurrent and newly diagnosed cases.

Related Experiment Videos

Main Results:

  • Strong evidence supports interstitial brachytherapy for recurrent malignant gliomas.
  • Efficacy in the adjuvant setting for newly diagnosed tumors requires further confirmation.
  • Effect of combined hyperthermia or chemotherapy is yet to be determined.

Conclusions:

  • Interstitial brachytherapy is a viable option for recurrent malignant gliomas.
  • Additional studies are necessary to establish its role in newly diagnosed gliomas.
  • Further investigation into combination therapies is warranted.